UnitedHealth Group (UNH) News Today

UnitedHealth Group Incorporated (NYSE: UNH) shares have increased as investors focus on the company’s potential for a profitability recovery ahead of its third-quarter earnings report. The bullish case is supported by valuation and margin improvement, but Medicare Advantage ratings, medical costs and execution remain key risks.

• Positive Sentiment: Analysts see UnitedHealth’s diversified healthcare platform, improving Medicare Advantage profitability and relatively low valuation as advantages over Humana. UnitedHealth vs. Humana: Which Healthcare Giant Has the Edge?
• Positive Sentiment: A bullish earnings preview argues that UnitedHealth’s decision to exit unprofitable business lines is driving significant margin expansion despite flat revenue and declining membership. At roughly 16 times expected 2027 earnings, the stock could have additional upside if management raises 2026 guidance or confirms durable margin gains. UnitedHealth: A Beat Is Priced In, But There’s Room For Surprise
• Positive Sentiment: UnitedHealth is scheduled to report third-quarter results before the market opens on October 13. Consensus expectations call for approximately $4.12–$4.15 in earnings per share and $111.4 billion in revenue, with earnings projected to rise sharply year over year as cost controls take effect. UnitedHealth Gears Up for Q3 Earnings
• Neutral Sentiment: New Medicare Advantage star-rating results are reshuffling the managed-care landscape. Humana benefited substantially, while UnitedHealth was described as holding steady; the changes may affect future bonus payments and competitive positioning, although the ratings shift may reflect methodology changes rather than a sudden change in care quality. Humana Soars on Improved Medicare Advantage Star Ratings
• Negative Sentiment: TD Cowen lowered its price target for UnitedHealth to $402, signaling more limited near-term upside and continued caution around the margin-repair outlook. Flat topline growth, shrinking membership and elevated medical costs remain obstacles to a sustained earnings recovery. UnitedHealth Group Price Target Lowered